Central pre-proglucagon derived peptides: opportunities for treatment of obesity

Current Pharmaceutical Design
Philip J LarsenMads Tang-Christensen

Abstract

Modern societies have moved from famine to feast and obesity and its co-morbidities now sweep the world as a global epidemic. Numerous scientific laboratories and pharmaceutical companies have taken the challenge and are now exploiting novel molecular targets for treatment of obesity. The pre-proglucagon system constitutes interesting candidates as potential targets for new anti-obesity drugs. In the periphery, pre-proglucagon derived peptides, Glucagon-Like Peptide-1 (GLP-1), Glucagon-Like Peptide-2 (GLP-2) and oxyntomodulin (OXM) are involved in a wide variety of physiological functions, including glucose homeostasis, gastric emptying, intestinal growth, insulin secretion as well as the regulation of food intake. Peripheral administration of GLP-1 derivatives and analogues to both rodents and man have shown promising effects on food intake and body weight suggesting that such therapies constitute potential anti-obesity treatment. In the central nervous system, pre-proglucagon and hence GLP-1, GLP-2 and OXM are exclusively found in a small population of nerve cells in the nucleus of the solitary tract. These constitute a neural pathway linking the "viscero-sensory" brainstem to hypothalamic nuclei involved in energy homeostasi...Continue Reading

Citations

Feb 3, 2007·Digestive Diseases and Sciences·Eldo E FrezzaMaurizio Chiriva-Internati
Jul 11, 2007·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Pengyun LiFaming Zhang
Oct 25, 2011·Expert Opinion on Investigational Drugs·Franco Folli, Rodolfo Guardado Mendoza
Jul 12, 2012·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·E E BlaakS Vinoy
Mar 16, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·S S TorekovJ J Holst
Mar 15, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C M MackA A Young
Jun 9, 2004·European Journal of Medicinal Chemistry·Cyril Sarrauste de MenthièreBernard Calas
Jan 6, 2005·Gastroenterology·April D Strader, Stephen C Woods

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

© 2022 Meta ULC. All rights reserved